Published in 2017, this case examines the impact measurement approaches of 13 GIIN members (including development finance institutions [DFIs], fund managers, banks, and foundations) who invest directly into healthcare delivery companies— detailing the metrics, methodologies, and assumptions that are commonly used by these investors, as well as the challenges and limitations they face.